データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Deutsche Bank Adjusts AbbVie Price Target to $180 From $175, Maintains Hold Rating
PureTech: White Most Recently Served as CFO at ImmunoGen Prior to AbbVie Acquisition >PRTC
PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
Seaport Therapeutics Names Lauren White as Chief Financial Officer
Should We Be Delighted With AbbVie Inc.'s (NYSE:ABBV) ROE Of 75%?
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
データなし
データなし